| Structure | Chemical Name | CAS | MF |
|
3-Amino-3-methyl-1-pentyne HCl
|
108575-32-2
|
C6H12ClN
|
|
4-Formylphenyl 4-chlorobenzoate
|
108577-34-0
|
C14H9ClO3
|
|
Albendazole BP Impurity L
|
108579-67-5
|
C12H15N3O2S
|
|
Poly(3-(2-methoxyethoxy)ethoxymethylthi&
|
108580-06-9
|
C10H16O3S
|
|
2-Furansulfonamide,5-methyl-(9CI)
|
108583-53-5
|
C5H7NO3S
|
|
3-{[(1-acetyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]amino}propanoic acid
|
108583-90-0
|
C13H16N2O5S
|
|
2-{[(1-acetyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]amino}-3-methylbutanoic acid
|
108583-92-2
|
C15H20N2O5S
|
|
(3S)-3,4-Dihydroxybutanoic acid ethyl ester
|
108585-47-3
|
C6H12O4
|
|
7-Oxabicyclo[2.2.1]hept-2-ene-2-carboxylic acid, ethyl ester
|
108586-21-6
|
C9H12O3
|
|
N-(Benzloxycarbonyl)-3-amino-1 2-
|
108587-40-2
|
C11H15NO4
|
|
methacryloxymethylphenethyltris(trimethylsiloxy)silane,mixed isomers
|
108587-59-3
|
C22H42O5Si4
|
|
2-amino-5-(N-ethylcarboxyamido)pentanoic acid
|
108589-72-6
|
C8H16N2O3
|
|
7-oxo-prostaglandin I2-ephedrine
|
108590-75-6
|
C30H45NO7
|
|
Ethanethioamide, 2-(formylmethylamino)- (9CI)
|
108591-63-5
|
C4H8N2OS
|
|
Methyl 2-ethyl-3-Methoxybenzoate
|
108593-43-7
|
C11H14O3
|
|
3-Methoxy-5-methyl-benzoic acid methyl ester
|
108593-44-8
|
C10H12O3
|
|
Methyl 3-ethoxybenzoate
|
108593-47-1
|
C10H12O3
|
|
2H-Oxireno[4,5]pyrano[3,2-c]pyridine(9CI)
|
108594-69-0
|
C8H5NO2
|
|
Rubidium fluoborate
|
108596-38-9
|
BF4Rb
|
|
1,7-Diazabicyclo[4.1.0]heptane-6-carboxamide,N-methyl-(9CI)
|
108602-78-4
|
C7H13N3O
|
|
2-Pyridinecarboxylicacid,3,4,5,6-tetrahydro-,methylester(9CI)
|
108602-80-8
|
C7H11NO2
|
|
2-Pyridinecarboxylicacid,1,4,5,6-tetrahydro-,methylester(9CI)
|
108602-82-0
|
C7H11NO2
|
|
Deoxyenterocin
|
108605-51-2
|
C22H20O9
|
|
5-indolylmethylhydantoin
|
108605-53-4
|
C12H11N3O2
|
|
2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide
|
108605-62-5
|
C12H9F3N2O2
|
|
Bis(benzo-15-crown-5)
|
108605-64-7
|
C28H38O10
|
|
traversianal
|
108605-66-9
|
C20H28O3
|
|
5-Hydroxy-2-[[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic acid
|
108605-69-2
|
C17H15NO6
|
|
Avenanthramidea
|
108605-70-5
|
C16H13NO5
|
|
H-Glu(OtBu)-NH2 HCl
|
108607-02-9
|
C9H19ClN2O3
|
|
H-Ala-Glu(OtBu)-NH2 HCl
|
108607-07-4
|
C12H24ClN3O4
|
|
1-fluoro-3-iodo-propane
|
108607-97-2
|
C3H6FI
|
|
2-{[(2E)-3-phenylprop-2-enoyl]amino}benzoic acid
|
108607-99-4
|
C16H13NO3
|
|
2-Styryl-4H-3,1-benzoxazin-4-one
|
108608-01-1
|
C16H11NO2
|
|
2-Propenoyl chloride, 3-(4-hydroxyphenyl)-, (2E)-
|
108608-03-3
|
C9H7ClO2
|
|
Ser-Asp-Gly-Arg-Gly
|
108608-63-5
|
C17H30N8O9
|
|
3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine
|
108610-78-2
|
|
|
Awd 122-60
|
108610-89-5
|
C18H23N5
|
|
6-(2-Hydroxypropoxy)-3,4'-bipyridine-5-carbonitrile
|
108611-04-7
|
|
|
6-[(2-Aminoethyl)amino]-2-methyl-3,4'-bipyridine-5-carbonitrile
|
108611-20-7
|
|
|
6-Methyl-5-phenyl-2-piperazino-3-pyridinecarbonitrile
|
108611-33-2
|
C17H18N4
|
|
Mizolastine
|
108612-45-9
|
C24H25FN6O
|
|
4-N-Boc-4-N-Methyl-aminopiperidine
|
108612-54-0
|
C11H22N2O2
|
|
2-((1-(1H-Benzimidazol-2-yl)-4-piperidinyl)methylamino)-4(1H)-pyrimidi none
|
108612-57-3
|
C17H20N6O
|
|
Mizolastine Impurity N
|
108612-60-8
|
C25H27FN6O
|
|
tert-butyldimethylsilyl trichloroacetate
|
108613-05-4
|
C8H15Cl3O2Si
|
|
2,6,7-Trioxabicyclo(2.2.2)octane, 1-(4-(3-methoxy-1-propynyl)phenyl)-4 -propyl-
|
108613-91-8
|
C18H22O4
|
|
2,6,7-Trioxabicyclo(2.2.2)octane, 1-(4-(phenylethynyl)phenyl)-4-propyl -
|
108613-93-0
|
C22H22O3
|
|
2,6,7-Trioxabicyclo(2.2.2)octane, 1-(4-(3,3-dimethyl-1-butynyl)phenyl) -4-propyl-
|
108613-94-1
|
C20H26O3
|
|
((4-(4-Propyl-2,6,7-trioxabicyclo(2.2.2)oct-1-yl)phenyl)ethynyl)trimet hylsilane
|
108613-97-4
|
C19H26O3Si
|
|
((4-(4-Cyclohexyl-2,6,7-trioxabicyclo(2.2.2)oct-1-yl)phenyl)ethynyl)tr imethylsilane
|
108614-08-0
|
C22H30O3Si
|
|
((4-(4-Butyl-2,6,7-trioxabicyclo(2.2.2)oct-1-yl)phenyl)ethynyl)trimeth ylsilane
|
108614-14-8
|
C20H28O3Si
|
|
((4-(4-Pentyl-2,6,7-trioxabicyclo(2.2.2)oct-1-yl)phenyl)ethynyl)trimet hylsilane
|
108614-16-0
|
C21H30O3Si
|
|
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane
|
108614-26-2
|
C16H18O3
|
|
2,6,7-Trioxabicyclo(2.2.2)octane, 4-butyl-1-(4-ethynylphenyl)-
|
108614-27-3
|
C17H20O3
|
|
2,6,7-Trioxabicyclo(2.2.2)octane, 1-(4-ethynylphenyl)-4-pentyl-
|
108614-29-5
|
C18H22O3
|
|
2,6,7-Trioxabicyclo(2.2.2)octane, 4-(2,2-dimethylpropyl)-1-(4-ethynylp henyl)-
|
108614-30-8
|
C18H22O3
|
|
Cefixime Impurity 9
|
108615-31-2
|
C16H17N5O8S2
|
|
5-Hexyn-2-one, 4-hydroxy-4-methyl- (9CI)
|
108615-48-1
|
C7H10O2
|
|
(S)-1-(4-chlorophenoxy)-3-Mercaptopropan-2-ol
|
108615-59-4
|
C9H11ClO2S
|
|
2-Hexen-1-one, 2,3-difluoro-1-(2-furanyl)-4-methyl-, (E)- (9CI)
|
108615-80-1
|
C11H12F2O2
|
|
Pyridine, 2-(2,2-difluoroethenyl)- (9CI)
|
108615-85-6
|
C7H5F2N
|
|
NIP 502
|
108616-42-8
|
C14H16ClN3O3
|
|
4AMINO3CYANOSTILBENE
|
108618-28-6
|
C15H12N2
|
|
4AMINO4CYANOSTILBENE
|
108618-29-7
|
C15H12N2
|
|
Ethyl 3'-nitro-[1,1'-biphenyl]-4-carboxylate
|
108620-55-9
|
C15H13NO4
|
|
4-Amino-2-o-tolyl-isoindole-1,3-dione
|
108620-87-7
|
C15H12N2O2
|
|
3-Hydroxy-2-(2-methylphenyl)-4(3H)-quinazolinone
|
108621-25-6
|
C15H12N2O2
|
|
N2-Benzyl-N1,N1-diethyl-1,2-propanediamine
|
108621-82-5
|
C14H24N2
|
|
1-(3-aminophenyl)-2-(methyl-pentyl-amino)ethanol
|
108621-85-8
|
C14H24N2O
|
|
4-Amino-N-benzyl-N-methylbenzenesulfonamide
|
108622-87-3
|
C14H16N2O2S
|
|
2,7-Naphthalenedisulfonic acid, 4-amino-6-5-(5-chloro-2,6-difluoro-4-pyrimidinyl)amino-2-sulfophenylazo-5-hydroxy-3-4-2-(sulfooxy)ethylsulfonylphenylazo-, lithium sodium salt
|
108624-00-6
|
C28H21ClF2N8O16S5.xLi.xNa
|
|
1,6-Dinitrocarbazole
|
108625-05-4
|
|
|
5-Chloro-2-((3-[(E)-3-(3-([5-chloro-3-ethyl-1,3-benzothiazol-2(3H)-ylidene]methyl)-5,5-dimethyl-2-cyclohexen-1-ylidene)-1-propenyl]-5,5-dimethyl-2-cyclohexen-1-ylidene)methyl)-3-ethyl-1,3-benzothiazol-3-ium iodide
|
108626-72-8
|
C39H43Cl2IN2S2
|
|
1H-Naphth[1,2-d]imidazole,6,7,8,9-tetrahydro-1-methyl-(6CI)
|
108629-36-3
|
C12H14N2
|
|
3H-Naphth[1,2-d]imidazole,6,7,8,9-tetrahydro-3-methyl-(6CI)
|
108629-37-4
|
C12H14N2
|
|
Naphth[1,2-d]imidazole, 6,7,8,9-tetrahydro-2-methyl- (6CI)
|
108629-59-0
|
C12H14N2
|
|
3'-Amino-3'-deoxy-5-methyluridine
|
108630-07-5
|
C10H15N3O5
|
|
4-(ethoxycarbonyl)oxane-4-carboxylic acid
|
108630-68-8
|
C9H14O5
|
|
(S)-2-Boc-amino-pent-4-enoic acid benzyl ester
|
108634-99-7
|
C17H23NO4
|
|
1-[1-(4-Fluorobenzyl)-1H-BenziMidazole-2yl]-N-Methyl-4-piperidineaMine
|
108635-83-2
|
C20H23FN4
|
|
UDP-3-O-(3-hydroxymyristoyl)-N-acetylglucosamine
|
108636-29-9
|
C31H53N3O19P2
|
|
D-Proline, 4-amino-5-oxo-, ethyl ester, (4S)-rel- (9CI)
|
108636-54-0
|
C7H12N2O3
|
|
Trimethyl[(2,3,4,5,6-pentakis([(trimethylsilyl)oxy]methyl)benzyl)oxy]s ilane
|
108638-04-6
|
|
|
1-(2,2-Diethoxyethoxy)-3-Methoxybenzene
|
108639-46-9
|
C13H20O4
|
|
tert-Butyl (1-(2-bromophenyl)ethyl)carbamate
|
108639-99-2
|
C88H171O8P
|
|
3-Methyl-3-aza-bicyclo[3.2.1]oct-8-ylamine
|
108640-12-6
|
C8H16N2
|
|
3-Methyl-3-aza-bicyclo[3.3.1]non-9-ylamine
|
108640-16-0
|
C9H18N2
|
|
3,5-dimethylmorpholine-4-carboxamidine
|
108641-44-7
|
C7H15N3O
|
|
3,5-Dimethylmorpholine-4-carboxamidinehemisulfatesalt
|
108641-45-8
|
C7H17N3O5S
|
|
Triaziridinecarboxaldehyde, 2,3-bis(1-methylethyl)-, (1alpha,2beta,3beta)- (9CI)
|
108641-73-2
|
C7H15N3O
|
|
DL-HOMOCYSTINE (3,3,3',3',4,4,4',4'-D8)
|
108641-82-3
|
C8H8D8N2O4S2
|
|
NEURODYE RH-461
|
108641-88-9
|
C25H37BrN3+
|
|
3-Penten-2-one, 3,4-difluoro-, (3E)- (9CI)
|
108642-84-8
|
C5H6F2O
|
|
3-Penten-2-one, 3,4-difluoro-, (3Z)- (9CI)
|
108642-94-0
|
C5H6F2O
|
|
Cyclohexene, 3-phenyl-1-(trimethylsilyloxy)-
|
108643-81-8
|
C15H22OSi
|
|
2,5-Heptadien-4-one, 2-methyl-6-[(1S)-4-methyl-3-cyclohexen-1-yl]-, (5E)-
|
108645-54-1
|
C15H22O
|
|
1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate
|
108645-62-1
|
C14H17NO4
|
|
1,2,3,4-Tetra-O-acetyl-alpha-D-arabinopyranose
|
108646-05-5
|
C13H18O9
|
|
nicotinamide arabinoside adenine dinucleotide
|
108646-17-9
|
C21H27N7O14P2
|